Slideshow

FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review

Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.

Related Videos
Robert J. Fox, MD; Andreas Muehler, MD, MBA
Sarah Anderson, PharmD, NBC-HWC
© 2024 MJH Life Sciences

All rights reserved.